Literature DB >> 21872633

Sero-epidemiology of measles-specific IgG antibodies and predictive factors for low or missing titres in a German population-based cross-sectional study in children and adolescents (KiGGS).

Christina Poethko-Müller1, Annette Mankertz.   

Abstract

BACKGROUND AND
OBJECTIVE: In the European Region, measles elimination is now targeted to 2015. To measure progress towards elimination age-group specific susceptibility targets have been defined. Age-specific measles susceptibility in children and adolescents was evaluated in Germany. Taking into account a broad range of socio-demographic, health- and vaccination status related variables, populations for vaccination campaigns were identified.
METHOD: We analysed data from children aged 1-17 years in the representative German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Measles immunoglobulin G antibodies were measured in 13,977 participants by enzyme immunoassay (ELISA). Bivariate and multivariate logistic regression analyses were used to determine parental and infant related factors associated with measles susceptibility.
RESULTS: The overall prevalence of seronegativity in children tested for measles IgG aged 1-17 years was 10.0% (95% CI 9.4-10.7). The prevalence of seronegativity in the German population was below the WHO targets for measles elimination in children aged 2-9 year-olds but exceeded the target for 10-17 year-olds. Age differences in the level of seronegativity were found to be mainly due to differences in vaccination coverage. A higher level of susceptibility was observed if parents did not comply with the request to present the child's vaccination card. In vaccinated children, immigration, male gender, very young age at first vaccination and a longer time period since last vaccination were associated with a higher level of susceptibility.
CONCLUSION: Further increase of the two-dose vaccination coverage is necessary in order to achieve the WHO targets. Catch up vaccination campaigns should focus on adolescents and immigrants.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21872633     DOI: 10.1016/j.vaccine.2011.08.081

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

Review 1.  Measles Status-Barriers to Vaccination and Strategies for Overcoming Them.

Authors:  Constanze Storr; Linda Sanftenberg; Joerg Schelling; Ulrich Heininger; Antonius Schneider
Journal:  Dtsch Arztebl Int       Date:  2018-10-26       Impact factor: 5.594

2.  Vaccination Coverage Disparities Between Foreign-Born and U.S.-Born Children Aged 19-35 Months, United States, 2010-2012.

Authors:  Aiden K Varan; Alfonso Rodriguez-Lainz; Holly A Hill; Laurie D Elam-Evans; David Yankey; Qian Li
Journal:  J Immigr Minor Health       Date:  2017-08

3.  High risk of a large measles outbreak despite 30 years of measles vaccination in The Netherlands.

Authors:  L Mollema; G P Smits; G A Berbers; F R Van Der Klis; R S Van Binnendijk; H E De Melker; S J M Hahné
Journal:  Epidemiol Infect       Date:  2013-08-06       Impact factor: 4.434

4.  Public health response to a measles outbreak on a university campus in Australia, 2015.

Authors:  J Smith; S Banu; M Young; D Francis; K Langfeldt; K Jarvinen
Journal:  Epidemiol Infect       Date:  2018-01-17       Impact factor: 4.434

5.  Seroprevalence of Measles Antibodies and Predictors for Seropositivity among Chinese Children.

Authors:  Xiaoqin Wang; Mei Ma; Zhaozhao Hui; Paul D Terry; Yue Zhang; Rui Su; Mingxu Wang; Wei Gu; Ling Li
Journal:  Int J Environ Res Public Health       Date:  2017-06-06       Impact factor: 3.390

6.  Sero-epidemiological study in prediction of the risk groups for measles outbreaks in Vojvodina, Serbia.

Authors:  Mioljub Ristić; Vesna Milošević; Snežana Medić; Jelena Djekić Malbaša; Smiljana Rajčević; Jasmina Boban; Vladimir Petrović
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

7.  Seroprevalence of measles-, mumps- and rubella-specific IgG antibodies in German children and adolescents and predictors for seronegativity.

Authors:  Christina Poethko-Müller; Annette Mankertz
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

8.  Vaccination coverage among children in Germany estimated by analysis of health insurance claims data.

Authors:  Thorsten Rieck; Marcel Feig; Tim Eckmanns; Justus Benzler; Anette Siedler; Ole Wichmann
Journal:  Hum Vaccin Immunother       Date:  2013-11-05       Impact factor: 3.452

Review 9.  Measles among migrants in the European Union and the European Economic Area.

Authors:  Gemma A Williams; Sabrina Bacci; Rebecca Shadwick; Taavi Tillmann; Bernd Rechel; Teymur Noori; Jonathan E Suk; Anna Odone; Jonathan D Ingleby; Philipa Mladovsky; Martin Mckee
Journal:  Scand J Public Health       Date:  2015-11-12       Impact factor: 3.021

10.  Serological assessment of the establishment of herd immunity against measles in a health district in Malaysia.

Authors:  Y Hazlina; M A Marlindawati; K Shamsuddin
Journal:  BMC Infect Dis       Date:  2016-12-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.